Clinical trial

Pilot Trial of Transnasal Nicotine in Parkinson Disease

NCT03865121

Study summary

ClinicalTrials.gov

Pilot Trial of Transnasal Nicotine in Parkinson Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY) Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-03-04

PhasePHASE2

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Interventions

Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY)DRUG

Sponsors & collaborators

El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarezlead sponsor

Howard Universitycollaborator

Mapped research locations

Mexico CityMexico1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03865121 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.